Am J Prev Med by Sipe, Theresa Ann et al.
Effects of Mental Health Benefits Legislation:
A Community Guide Systematic Review
Theresa Ann Sipe, PhD, MPH, Ramona K.C. Finnie, DrPH, MPH, John A. Knopf, MPH, Shuli 
Qu, MPH, Jeffrey A. Reynolds, MPH, Anilkrishna B. Thota, MBBS, MPH, Robert A. Hahn, 
PhD, MPH, Ron Z. Goetzel, PhD, Kevin D. Hennessy, PhD, Lela R. McKnight-Eily, PhD, 
Daniel P. Chapman, PhD, Clinton W. Anderson, PhD, Susan Azrin, PhD, Ana F. Abraido-
Lanza, PhD, Alan J. Gelenberg, MD, Mary E. Vernon-Smiley, MD, MPH, Donald E. Nease Jr., 
MD, and The Community Preventive Services Task Force
Community Guide Branch, Division of Epidemiology, Analysis, and Library Services, Center for 
Surveillance, Epidemiology, and Laboratory Services (Sipe, Finnie, Knopf, Qu, Reynolds, Thota, 
Hahn), Division of Population Health (McKnight-Eily, Chapman), and Division of Adolescent and 
School Health, (Vernon-Smiley), CDC; Emory University, Truven Health Analytics, and Thomson 
Reuters (Goetzel), Atlanta, Georgia; American Psychological Association (Anderson), 
Washington, District of Columbia; Substance Abuse and Mental Health Services Administration 
(Hennessy), Rockville; National Institute of Mental Health (Azrin), Bethesda, Maryland; Mailman 
School of Public Health, Columbia University (Abraido-Lanza), New York, New York; Department 
of Psychiatry, Penn State Hershey Medical Center (Gelenberg), Hershey, Pennsylvania; and the 
American Academy of Family Physicians (Nease), Denver, Colorado
Abstract
Context—Health insurance benefits for mental health services typically have paid less than 
benefits for physical health services, resulting in potential underutilization or financial burden for 
people with mental health conditions. Mental health benefits legislation was introduced to improve 
financial protection (i.e., decrease financial burden) and to increase access to, and use of, mental 
health services. This systematic review was conducted to determine the effectiveness of mental 
health benefits legislation, including executive orders, in improving mental health.
Evidence acquisition—Methods developed for the Guide to Community Preventive Services 
were used to identify, evaluate, and analyze available evidence. The evidence included studies 
published or reported from 1965 to March 2011 with at least one of the following outcomes: 
access to care, financial protection, appropriate utilization, quality of care, diagnosis of mental 
illness, morbidity and mortality, and quality of life. Analyses were conducted in 2012.
Evidence synthesis—Thirty eligible studies were identified in 37 papers. Implementation of 
mental health benefits legislation was associated with financial protection (decreased out-of-
pocket costs) and appropriate utilization of services. Among studies examining the impact of 
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legislation strength, most found larger positive effects for comprehensive parity legislation or 
policies than for less-comprehensive ones. Few studies assessed other mental health outcomes.
Conclusions—Evidence indicates that mental health benefits legislation, particularly 
comprehensive parity legislation, is effective in improving financial protection and increasing 
appropriate utilization of mental health services for people with mental health conditions. 
Evidence is limited for other mental health outcomes.
Context
The domestic disease burden of mental health (MH) disorders (including substance use) is 
well established.1–4 Nearly 20% of U.S. adults reported a diagnosable mental illness in 
2012,5 and nearly 50% will experience at least one during their lifetime.1–4 A 1999 U.S. 
Surgeon General’s report estimates that mental illness is the second largest contributor to 
disease burden in established market economies such as the U.S.6
Moreover, untreated and undertreated MH disorders contribute to the high domestic 
burden.7–9 In a 2012 national survey, only 62.9% of adults with a serious mental illness had 
received any MH services in the past year and only 10.8% of 23.1 million individuals with 
substance use disorders had been treated.10 Many affected people cite cost as a major factor 
preventing them from seeking health care.5,6,9,11 In 2009, more than half of American 
families reported limiting health care in the previous year because of cost, and nearly 20% 
indicated substantial financial concerns associated with medical bills.9,11
Mental health benefits legislation (MHBL) involves changing regulations for MH insurance 
coverage to improve financial protection (i.e., decrease financial burden) and to increase 
access to, and use of, MH services including substance abuse (SA) services. Such legislation 
can be enacted at the federal or state level and categorized as:
1. parity, which is on a continuum from limited (covering only a few mental illnesses) 
to comprehensive (covering all mental illness), with varying degrees of benefits; or
2. mandate laws, which: (1) provide some specified level of MH coverage; (2) offer 
option of MH coverage; or (3) require a minimum benefits level if providing MH 
coverage.
Thus, MHBL is intended to reduce out-of-pocket costs and increase access to care, creating 
the potential for increased utilization among those in need of MH services.
Legislative Context
Prior to enactment of comprehensive MH/SA parity legislation, health insurance plans 
generally offered less-extensive coverage for MH/SA services compared with physical 
health services.12 Three federal laws—the 1996 MH Parity Act13 (MHPA, Title VII), the 
2008 Paul Wellstone and Pete Domenici MH Parity, Addiction Equity Act14 (MHPAEA, 
Subtitle B), and the Affordable Care Act (ACA)15—have addressed parity in MH and 
MH/SA benefits.16 As of January 2014, mandate legislation had been passed by 49 states 
and the District of Columbia.17
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The first official MH/SA insurance parity action occurred in 1961 through an executive 
order requiring the Federal Employees Health Benefits (FEHB) Program to cover 
psychiatric illnesses at a level equivalent to general medical care.18 Parity was offered in 
two FEHB insurance plans from 1967 until 1975, when it was discontinued because of 
increases in cost and utilization associated with adverse selection and moral hazard.a,19,20 
The uptake of managed care as a mechanism for reducing “inappropriate” utilization of 
services in the late 1980s and early 1990s provided economic feasibility and renewed the 
political viability of MH/SA parity legislation.21,22
The first federal parity law in 1996, the MHPA, required lifetime and annual limits for MH 
services to be no different than physical health services.16 The legislation was limited with 
no provisions for parity in SA services, treatment limitations, or cost-sharing mechanisms. 
Thus, the legislation had little impact, although it served as a catalyst for subsequent MHBL, 
particularly at the state level.23 In 1999, a second executive order was issued to implement 
full parity in the FEHB Program, extending MH/SA parity to approximately 8.5 million 
beneficiaries.24 The second federal legislation in 2008, the MHPAEA, was part of the 
Emergency Economic Stabilization Act.17,25 The MHPAEA was more comprehensive, 
requiring that financial requirements and treatment limitations beyond annual and lifetime 
dollar limits for MH/SA be no different than those for physical health.26 However, the 
MHPAEA retained exemptions for employers with ≤50 employees or demonstrating a 2% 
cost increase annually as a result of the legislation. The most recent federal legislation, the 
ACA in 2010, extended existing federal MH/SA parity requirements and differed from 
previous federal legislation by requiring: (1) qualified health plans to offer MH and SA 
coverage; and (2) coverage of specific MH/SA services for certain health plans.15 See 
Appendix A (available online) for more details.
The purpose of this systematic review was to summarize and assess evidence on the 
effectiveness of MHBL in improving MH and related outcomes.
Evidence Acquisition
The Community Guide systematic review process was used to assess the effectiveness of 
MHBL.27,2829 The process involved forming a systematic review team to work with 
oversight from the independent, nonfederal, unpaid Community Preventive Services Task 
Force (Task Force), to develop evidence-based recommendations.
Conceptual Approach and Analytic Framework
The conceptual approach depicting inter-relationships among interventions, populations, and 
outcomes is represented in the analytic framework (Figure 1). The team hypothesized that 
MHBL will affect the insured population through reductions in MH/SA coverage restrictions 
and through increases in MH/SA benefits offered. This will lead to improvements in access 
to care and financial protection, which may increase appropriate utilization, diagnosis, and 
aAdverse selection occurs when people in poor health enroll in insurance plans that offer more-extensive benefits, resulting in a higher 
risk pool in those health plans. Moral hazard occurs when people in healthcare plans with reduced out-of-pocket costs use services at 
higher rates than people in plans with greater costs. (Frank RG, Koyanagi C, McGuire TG. The politics and economics of mental 
health “parity” laws. Health Affairs. 1994;(4):108–119.)
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quality of care. Subsequent reductions in morbidity and mortality and improvements in 
quality of life are expected. Managed care is included as an effect modifier implemented 
before, concurrent with, or after MHBL, and expected to offset anticipated increases in cost 
and utilization from MHBL.
Research Questions
This review addressed a comprehensive research question: Is legislation for MH/SA benefits 
effective in improving MH in the community by increasing (1) access to care, (2) financial 
protection, (3) appropriate utilization of MH services, (4) diagnosis of mental illness, and (5) 
quality of care; by reducing (6) morbidity and (7) mortality; and by improving (8) quality of 
life?
Outcome Measures Used to Determine Effectiveness
Outcomes assessed in this review are defined briefly here. See Appendix B (available 
online) for full definitions and examples.
1. Access to care. The ability of those with public or private insurance to obtain 
MH/SA care including workforce coverage for MH/SA benefits.
2. Financial protection. The reduction in out-of-pocket costs paid by an individual 
for MH/SA services; includes measures of out-of-pocket spending.30,31
3. Appropriate utilization. Receiving the proper amount and quality of services 
when needed, including: (1) utilization of MH/SA services by people in need; (2) 
services rendered by MH specialists (e.g., psychiatrist, psychologist, social 
worker); or (3) receipt of services consistent with evidence-based guidelines for 
MH/SA care.
4. Diagnosis. The determination that a person meets established criteria for an MH 
condition.
5. Quality of care. Health services that are likely to result in the desired health 
outcomes and are consistent with current professional knowledge.32
6. Morbidity. The presence of any MH condition, such as depression.
7. Mortality. Any death associated with an MH condition, such as suicide.
8. Quality of life (health-related). Perception of physical and mental health over 
time.33
Search for Evidence
Eighteen bibliographic databases were searched from their inception through March 2011. 
Other sources included reference lists; suggestions from team members and other subject 
matter experts; and searches through Internet portals, Google, and the National Council on 
State Legislatures website.17 The search included terms related to parity, MH, SA, and 
insurance. Search terms and strategy are available at www.thecommunityguide.org/
mentalhealth/SS-benefitslegis.html.
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Inclusion criteria—Studies were included if they: (1) evaluated an intervention relating to 
MHBL, including executive orders at the federal or state level; (2) measured and reported at 
least one review outcome; and (3) were reported in English.
Exclusion criteria—Studies were excluded if they were: (1) based primarily on 
simulation data; (2) reforms to restructure care only, such as Medicaid waivers; (3) single-
disease mandates, such as coverage mandate for autism only; and (4) implemented outside 
the U.S., because of differences in health systems and legislation.
Abstraction and Evaluation of Studies
Two reviewers evaluated each study using an adaptation of a standardized abstraction form, 
which included a quality assessment (www.thecommunityguide.org/methods/
abstractionform.pdf).29 Disagreements were resolved by discussion and team consensus. 
DistillerSR, version 1 was used to manage references, screen citations, and abstract data. 
Microsoft Excel, 2010 was used for effect size calculation and other analyses. Papers based 
on the same study data set were linked; only the paper with the most complete data (e.g., 
longest follow-up) was included in analyses. See Appendix C (available online) for more 
details.
Summarizing the Body of Evidence on Effectiveness
Effect measurement and data synthesis—Effect estimates of absolute percentage 
point (pct pt) change or relative percentage change were calculated with corresponding 95% 
CIs and adjusted for baseline data when possible. Regression coefficients or ORs were used 
as the effect estimates when reported.
Summary effect estimates (medians), interquartile intervals (IQIs), and number of studies 
are reported when outcomes contained five or more data points. Results for most outcomes 
of interest were synthesized descriptively and p-values are reported when available. Tables 
illustrating the effect direction are used to display effects based on methods developed by 
Thomson and Thomas34 (see Appendix C, available online, for formulas and details on data 
synthesis). Analyses were conducted in 2012.
Subgroup analyses—Two comparisons were assessed qualitatively: (1) stronger parity 
legislation versus no or weak parity legislation35–37; and (2) mutually exclusive categories 
of parity versus no or weak parity legislation.38–40 Categories of parity were based on 
primary author’s definitions.
Subgroup analyses were also planned to compare outcomes by settings (e.g., U.S. states), 
clients (e.g., age group, racial and ethnic group, type of mental illness), employer size, and 
health plan type (e.g., public versus private).
Economic Evaluation
The methods and findings of the economic evaluation of MHBL interventions are described 
elsewhere (www.thecommunityguide.org/mentalhealth/RRbenefitslegis.html).
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A total of 15,341 papers were identified from the literature search and screened by title and 
abstract (Figure 2). Further detailed review of full-text papers produced 30 quasi-
experimental and observational studies from 37 papers that met inclusion criteria. Of these, 
11 studies (reported in 16 papers12,24,38–51) were of greatest design suitability, nine 
(reported in ten papers20,35–37,52–55,56,57) were of moderate suitability, and ten (reported in 
11 papers58–68) were least suitable. Twelve studies (reported in 18 
papers20,24,37,41,43–47,49–52,55–57,61,62) were of good quality of execution and 18 (reported in 
19 papers12,35,36,38–40,42,48,53,54,57–60,63–68) were fair. Twenty-eight studies (reported in 35 
papers12,20,24,35–55,57–63,65–68) examined effects of state or federal MH/SA parity policies or 
legislation, and two56,64 examined effects of state-mandated coverage for MH and SA. Six 
studies35,37–40,42 examined effects of comprehensive parity legislation or policies. No 
studies evaluated the 2010 ACA. Most studies used a nationwide sample to examine effects 
of federal legislation or state mandates, and were conducted between 1990 and 2011.. 
Summary evidence tables that present further details of each study are provided at 
www.thecommunityguide.org/mentalhealth/SET-benefitslegis.pdf. No prior systematic 
reviews on the effectiveness of MHBL were found in the literature.
Overall Results
Access to care—Seven studies in eight papers39,53,60,63–66,68 reported changes in access 
to care, and three studies in four papers60,63,64,68 (eight data points) reported percentage 
change of employees with coverage for MH/SA services. Median absolute pct pt increase 
for employees covered by MH/SA services was 13.6 (IQI= −3.8, 48.0). Four 
studies39,53,65,66 provided additional evidence. One of those65 reported that restrictions for 
MH/SA remained greater than restrictions for physical health services for 89% of plans after 
implementation of the 1996 MHPA. Another study66 reported the percentage of employers 
covering MH/SA benefits before and after MHPA implementation for specific services; 
overall results suggested no change in proportion of employers covering MH/SA benefits. 
Two studies39,53 found that more people with an MH need (including SA) perceived their 
access to MH/SA care to be easier after implementation of a state parity mandate, with 
increases of 8.1 and 3.3 pct pts (p>0.05), respectively.
Financial protection—Five studies in six papers assessed financial 
protection,36,44,47,51,52,67 and effectiveness was shown for all financial-protection outcomes. 
One study36 found the proportion of people reporting out-of-pocket spending of >$1,000 
and people reporting a financial burden for children’s MH care in parity states was 7.1 and 
9.4 pct pts less, respectively, than for people in non-parity states. Two studies with seven 
study arms52,67 reported that MHBL was associated with a median decline of 4.6 pct pts 
(IQI= −12.0, −4.0) in the percentage of overall out-of-pocket healthcare spending used to 
pay for MH services. Two studies reported in three papers44,47,51 found an overall decrease 
in MH out-of-pocket spending per user comparing those covered under FEHB versus those 
covered by self-insurance plans: one47 reported an annual median decline of $9 in adult-only 
plans (from baselines of $202–$257); similarly, another51 reported an annual median decline 
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of $37 in child and adult plans (from baselines of $251–$418) and a subgroup analysis44 
also reported an annual median decline of $51 in child-only plans (from baselines of $724–
$1,131).
Appropriate utilization—Nine studies assessed appropriate utilization as an increase in 
the number of: (1) visits to MH specialists35,39,42,56; (2) evidence-based or guideline-
concordant care visits24,40; or (3) MH visits for people with a MH need.12,35,38,39,46 In 
general, studies reported positive effect estimates following MHBL (specifically, state 
mandates, FEHB, or Medicare parity in cost sharing). Three studies35,39,42 reported greater 
MH specialist service use in those states with parity laws compared to those without (Table 
1). Two studies24,40 reported increases in adoption of guideline-concordant care as a result 
of MH parity implementation (Table 2). Effects of MH parity on increasing service 
utilization among populations identified as having an MH need, reported in five 
studies,12,35,38,39,46 are shown in Table 3. All five studies reported increased service 
utilization among populations in need.
Diagnosis of mental health conditions—One study in two papers20,24 reported 
relative increases of 13.0% in identification of major depressive disorders and 25.6% in SA 
disorders, and absolute increases of 0.3 pct pts (p<0.05) and 0.1 pct pts, respectively, 
following implementation of the FEHB parity policy.
Morbidity—One study46 assessed the effect of state parity mandates on MH-related 
morbidity. In five states that enacted state parity mandates during the study period, there was 
a 3.2-pct pt decrease in the prevalence of people reporting poor MH. Similarly, the 
prevalence of people reporting poor MH was 2.8 pct pts lower in states that had state 
mandated parity for the entire study period than for those without.
Mortality—Two studies37,41 reported evidence on reduced suicide rate using national data 
from the same source. Klick and Markowitz37 conducted a two-stage least squares 
regression, controlling for state-level variables, and reported regression coefficients of 
−0.145 for partial parity versus −0.212 for full parity states, indicating a reduced suicide 
rate. However, neither of these results was significant (p>0.05). In a similar study using 
updated classification of state parity status, Lang41 found, among states that enacted parity 
mandates, the suicide rate per 100,000 decreased significantly by a relative 5% (p<0.01) 
compared with states that enacted no or weak parity mandates.
Quality of care and quality of life—In this review, no independent measures of quality 
of care or quality of life were reported.
Subgroup analyses—Overall, six studies35,37–40,42 examined the impact of strength and 
scope of legislation on the outcomes of utilization, appropriate utilization, and suicide rates 
(Table 4). The first group of studies had an indirect comparison of the effectiveness of 
comprehensive parity versus no/weak parity to the effectiveness of all types of parity versus 
no/weak parity (the categories of parity are not mutually exclusive; Table 4, top). The 
second set of studies (Table 4, bottom) had an indirect comparison of comprehensive parity 
to more limited forms of parity (i.e., weaker parity); these categories are mutually exclusive.
Sipe et al. Page 7













Additional evidence on utilization—Sixteen studies in 18 
papers12,20,38,39,43,44,46–52,54,56,59,61,62,67 reported utilization of MH or SA services but did 
not provide sufficient information to meet the criteria for appropriate utilization. Results 
were mixed (see Appendix D, available online, for more details).
Applicability
All studies were conducted in the U.S., among people who were covered by private or 
public insurance. Analysis by age36,44 indicated that effects for financial protection were 
similar for children and adults. Analysis by region43,44,60,64,68 and employer 
size46,52,60,65,66 showed no difference in access to care. No studies reported outcomes by 
health plan type or racial/ethnic minority groups; however, the body of evidence includes 
national samples that should be representative of all health plan types and racial/ethnic 
groups.
One study40 reported evidence on effectiveness in low-SES populations for appropriate 
utilization among Medicare enrollees aged ≥65 years; MH benefit changes were most 
effective for people in the lowest income and education groups (p<0.05). Another study46 
found that employees working for small employers (<100 employees) were more likely to 
use MH services after implementation of state parity mandates, regardless of income, and 
state parity mandates were most effective in increasing utilization of any MH service for 
people in the lowest income group (p<0.05). In summary, the body of evidence is applicable 
to the insured population across the U.S., with some evidence for specific outcomes on 
children, low-income and low-education groups, and employees of small employers. MHBL 
does not apply to the uninsured population.
Additional Benefits and Harms
One study56 in this review suggested that increased MH service use after implementation of 
MHBL might have an additional benefit of decreasing utilization of social or other health 
services, because of the association between mental and physical health.56,69 These 
authors56 and others70,71 have speculated that insurance coverage–related discrimination for 
MH could decrease as a result of legislation because insurance providers would no longer be 
able to refuse coverage for these conditions.
Two potential harms of MHBL described earlier are moral hazard and adverse selection. No 
studies in this review provided evidence on moral hazard. However, increased adverse 
selection was found in one study61 following implementation of a state parity law, but only 
in a subgroup that allowed beneficiaries to choose among health plans.
Some researchers have suggested that employers may drop MH/SA coverage to avoid being 
subject to MHBL.72,73 A national study conducted in 201073 found that although 5% of 
employers dropped MH/SA coverage that year, only 2% reported dropping coverage after 
passage of the 2008 MHPAEA. The U.S. General Accounting Office 2011 Mental Health 
and Substance Abuse Report72 found similar results, showing that approximately 2% of 
employers discontinued coverage in 2010 of either: (1) MH and substance use; or (2) only 
substance use disorders. Current provisions of the 2010 ACA will require state Medicaid 
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programs and insurance plans in state health insurance exchanges to cover both MH and SA 
as one of ten categories of essential health benefits in 2014.74,75
Considerations for Implementation
Challenges to effective implementation of MHBL include underutilization, access to 
services, and exemptions. This legislation alone is not sufficient to address underutilization 
of MH/SA services in the U.S.10 Additionally, it is unclear to what extent MHBL reduces 
public stigma, a barrier to utilization of MH/SA services.76–78 Low awareness of legislative 
provisions also may hinder service utilization by beneficiaries.79
Conversely, limited numbers of MH providers80 and inpatient beds81 restrict access to 
services, especially in rural areas.81 In some cases, covered services and treatments are not 
clearly defined in the legislation, allowing individual health plans to limit benefits provided 
for certain conditions or illnesses.82 Further, investigational treatments typically are not 
covered by insurance plans, thus limiting access to care.82
Another implementation issue concerns exemptions that may decrease the potential reach of 
MHBL. Larger employers often self-insure, and are therefore exempt from MH insurance–
related state mandate laws because of the 1974 Employee Retirement Income Security Act 
(ERISA).83 Both employers with <50 employees and group health plans that demonstrate an 




Results of this review suggest that MHBL has favorable effects on financial protection and 
access to care. Evidence on increasing appropriate utilization of MH services and certain 
evidence on aspects of MH care (e.g., increased diagnosis of mental illness) is also 
favorable, with larger effects for comprehensive parity legislation. In addition, MHBL, and 
specifically comprehensive parity, is associated with favorable effects for health-related 
outcomes of reducing suicides and morbidity, although the small number of studies limits 
inferences.
Discussion
MHBL creates levels of financial protection and access to care that are no more restrictive 
for certain insured individuals seeking MH/SA services than for those seeking services for 
physical health conditions.26 Nonetheless, accurately interpreting these results requires 
consideration of two caveats:
1. Simultaneous implementation of MHBL and adoption of managed care have made 
isolating the effects of MHBL difficult. Overall, the interrelationship between 
managed care and MHBL is unclear; managed care might reduce moral hazard and 
ensure appropriateness of services rendered following improved financial 
protection84 or it might restrict access to services through excessive or 
inappropriate use of management tools.56 Further, some parity legislation applies 
Sipe et al. Page 9













only to managed care insurance plans, or explicitly authorizes and encourages the 
use of managed care.84
2. Of 37 included papers, 35 examined effects of state, federal, or executive-ordered 
MH/SA parity, whereas the remaining two papers56,64 investigated effects of 
mandating coverage for MH and SA for only the outcomes of access and 
utilization. Therefore, effects on most outcomes can be associated with some level 
of parity legislation.
The 2010 ACA affects MH/SA parity in two critical ways. First, the ACA extends the reach 
of the two previous federal parity laws to certain types of health plans not previously 
required to comply.17,74 Second, ACA contains provisions mandating that: (1) MH and SA 
services in general are covered by certain health insurance issuers; and (2) specific MH and 
SA disorder services are covered by specified plan types (i.e., qualified health plans, certain 
Medicaid plans, and plans offered through the individual market).17,74 Combined, these two 
new provisions extend the requirements and reach of MH/SA parity.
Limitations
A number of challenges in studying the effects of MHBL were limitations in the current 
review but do not threaten validity of findings substantially. First, there was difficulty 
isolating the effects of managed care from those of MHBL. Second, many studies did not 
report sufficient information to assess appropriate utilization. Third, there is potential for 
data dependency (i.e., same people or populations represented more than once in the body of 
evidence). Some studies in this review used the same national data sources, such as the 
Healthcare for Communities survey85 or MarketScan database,86 but the extent of overlap is 
unclear. Fourth, data sources might introduce bias either through survey data, which are 
based on self-reporting and potentially subject to recall bias or claims data, which might lead 
to spuriously low results for MH/SA service use because of under-reported diagnoses and 
underutilization of treatment.45 Fifth, classifications of strength of state parity mandates 
differed across studies. Although many authors relied on the National Conference of State 
Legislatures,17 others used alternative sources or their own classification. Sixth, few studies 
of private employer plans controlled for exemptions, such as the 1974 ERISA, which 
exempts self-insured employers (typically large employers with >500 employees) from state 
mandates.83 Additionally, no studies controlled for the small employer exemption (≤50 
employees) or cost exemption (1%–2% cost increase following parity implementation) of 
the two federal laws.16 Failure to control for these exemptions could lead to underestimates 
of MHBL effects.
Evidence Gaps
Research evaluating effects of MHBL on MH outcomes is limited. Studies are needed to 
assess effects of legislation on morbidity (e.g., symptom reduction remission and recovery), 
mortality, quality of life, and aspects of quality of care (e.g. intensity and duration of 
treatment, and coordination of care). Most studies that reported utilization did not assess 
appropriateness of use as indicated by guideline-concordant care or patient need. In addition, 
researchers often reported outcomes that combined inpatient and outpatient utilization, but 
the desired direction (i.e., increase or decrease) differed with various patient conditions. 
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Reporting types of utilization separately and including measures of appropriate utilization 
will allow for assessments of appropriate care.
Research is also needed to clarify the role of MHBL in reducing health-related disparities 
and improving MH outcomes among subgroups (e.g., low-SES groups, racial/ethnic 
minorities, and various MH conditions) that may experience greater issues with access to 
care and impairments. Moreover, evidence is limited for people covered by public health 
insurance (e.g., Medicaid and Medicare). Further, evaluations are needed to examine effects 
of the 2008 MHPAEA, which contains more requirements for parity than the 1996 MHPA 
and the 2010 ACA, which currently has provisions to establish parity for MH/SA in many 
insurance plans in 2014.74 Finally, studies that include a longer follow-up (>3 years) are 
necessary to assess long-term effects of MHBL.
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Appendix A: Affordable Care Act
PART I—ESTABLISHMENT OF QUALIFIED HEALTH PLANS
SEC. 1301. QUALIFIED HEALTH PLAN DEFINED
(a) Qualified Health Plan.—In this title: (1) In general.—The term “qualified health plan” 
means a health plan that—(A) has in effect a certification (which may include a seal or other 
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indication of approval) that such plan meets the criteria for certification described in section 
1311(c) issued or recognized by each Exchange through which such plan is offered; (B) 
provides the essential health benefits package described in section 1302(a); and (C) is 
offered by a health insurance issuer that— (i) is licensed and in good standing to offer health 
insurance coverage in each State in which such issuer offers health insurance coverage under 
this title (ii) agrees to offer at least one qualified health plan in the silver level and at least 
one plan in the gold level in each such Exchange; (iii) agrees to charge the same premium 
rate for each qualified health plan of the issuer without regard to whether the plan is offered 
through an Exchange or whether the plan is offered directly from the issuer or through an 
agent; and (iv) complies with the regulations developed by the Secretary under section 
1311(d) and such other requirements as an applicable Exchange may establish.
(Source: Patient Protection and Affordable Care Act (H.R. 3590) Public Law 111-148; 2009. 
pp. 44–45)
Appendix B: Mental Health Outcome Definitions and Examples
Access to care
The ability of those with public or private insurance to obtain MH/SA care. Examples 
include workforce coverage for mental health/substance abuse (MH/SA) benefits and 
insured’s perception of that coverage.
Financial protection
The reduction in out-of-pocket costs paid by an individual for MH/SA services.1,2 Examples 
include measures of decreased financial burden, dollar amount, and percentage of out-of-
pocket spending.
Appropriate utilization
Receiving the proper amount and quality of services when needed, including utilization of 
MH/SA services by people with a MH/SA need, services rendered by MH specialists (e.g., 
psychiatrist, psychologist, social worker), or receipt of services conforming to evidence-
based guidelines for MH/SA care.
Diagnosis
The determination that a person meets established criteria for a MH condition. Examples 
include recognition of newly identified mental health–related conditions, such as depression 
or substance abuse.
Quality of care
“The degree to which health services for individuals and populations increase the likelihood 
of desired health outcomes and are consistent with current professional knowledge.” 
Examples include; appropriateness of treatment; type, intensity, and duration of treatment; 
patient satisfaction; and coordination of care.3
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The presence of any type of MH condition. Examples include measures of MH status; 
reduced morbidity includes reduction in symptoms as measured by standardized and 
validated instruments such as Mental Health Inventory Scale (MHI-5; amhocn.org/static/
files/assets/bae82f41/MHI_Manual.pdf), Kessler 6 distress scale (K6; www.cdc.gov/
mentalhealth/data_stats/nspd.htm), increased remission, increased recovery, and decreased 
relapse. In this review, the team accepted cutoff scores used by primary study authors.
Mortality
Any death associated with a MH condition Examples include suicides, deaths related to 
eating disorders, and alcohol and drug (i.e., substance) abuse.
Quality of life
Health-related quality of life, “an individual’s or group’s perceived physical and mental 
health over time.”4 Outcome measures that report health-related quality of life include the 
Medical Outcomes Study Short Forms 125 and 36,6 the Sickness Impact Profile,7 and 
Quality of Life Index for Mental Health.8
Appendix C: Data Abstraction and Synthesis
Abstraction and Evaluation of Studies
Two reviewers read and evaluated each study that met inclusion criteria using an adaptation 
of a standardized abstraction form (www.thecommunityguide.org/methods/
abstractionform.pdf)9 that included data describing elements of mental health benefits 
legislation, population characteristics, study characteristics, study results, applicability, 
potential harms, additional benefits, and considerations for implementation. Assessment of 
study quality included study design and execution, which were evaluated using these 
criteria: studies with greatest design suitability were those with prospective data on exposed/
comparison populations; studies with moderate design suitability were those with 
retrospective data on exposed/comparison populations or with data collected at multiple pre 
and post-intervention time points; studies with least-suitable designs were cross-sectional 
studies with no comparison population (including one-group single pre- and post-
measurement). Studies were assigned limitations for quality of study execution based on 
seven categories of threats to validity identified in studies, up to a total of nine limitations 
across six categories: (1) description of study population and intervention to include at least 
year of intervention, study location and population characteristics (one limitation); (2) 
sampling to include representation, selection bias, and appropriate control group (one 
limitation); (3) measurement of exposure to include reliability of outcome and exposure 
variables (two limitations); (4) data analysis to include appropriate statistical tests and 
controls (e.g., time, intensity, secular trends, plan types, condition of patient, etc.) and 
adjustment for multi-year data (one limitation); (5) interpretation of results/sources of 
potential bias to include attrition < 80%, comparability of comparison group, recall bias for 
surveys, accounting for overlapping laws and adequate controls for confounding (three 
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limitations), and (6) other issues such as missing data (one limitation). Study quality of 
execution was characterized as good (0–1 limitation), fair (2–4 limitations), or limited (≥5 
limitations). Studies with good or fair quality of execution and any level of design suitability 
were included in the analyses. Papers based on the same study dataset were linked; only the 
paper with the most complete data (e.g., longest follow-up) for each outcome was included 
in each analysis.
Studies were stratified by five subgroups when data were available: strength and scope of 
legislation, setting, clients, employer size, and health plan type.
Effect Measurement and Formulas
Effect estimates for absolute percentage point change and relative percentage change were 
calculated using the following formulas:
For studies with pre- and post-measurements and concurrent comparison groups:
where:
Ipost = last reported outcome rate or count in the intervention group after the 
intervention;
Ipre = reported outcome rate or count in the intervention group before the intervention;
Cpost = last reported outcome rate or count in the comparison group after the 
intervention;
Cpre = reported outcome rate or count in the comparison group before the intervention.
Effect estimates for studies with pre- and post-measurements but no concurrent comparison:
Outcome data were reported as proportions when possible and were converted to effect 
estimates of absolute percentage point change or relative percent change.
Summarizing and Synthesizing the Body of Evidence on Effectiveness
The rules of evidence under which the Community Preventive Services Task Force makes 
its determination address several aspects of the body of evidence, including the number of 
studies of different levels of design suitability and execution, consistency of the findings 
among studies, public health importance of the overall effect estimate, and balance of 
benefits and harms of the intervention.9–11
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Appendix D: Detailed Tables of Results and Additional Evidence
Table D-1
Results of Studies Evaluating the Effect of Mental Health Parity Legislation on Utilization 
of Specialty Mental Health Provider Services
Author, year Comparison Outcome Effect estimate Direction
McGuire, 198212 States with a mandate vs. 
states without a mandate
Use of psychiatrists’ 
services
Absolute pct pt change: 9.2 Favorable
Use of psychologists’ 
services
Absolute pct pt change: 18.0
Pacula, 200013 Parity states vs. non-parity 
states
Number of specialty 
MH visits




Bao, 200414 Strong parity states vs. 
weak parity states
Number of specialty 
MH visits
Difference-in-Difference-in 
Difference (DDD): 8.9, 
SE=4.9, p<0.10
Favorable
Barry, 200515 Parity states vs. non-parity 
states
Number of specialty 
MH visits
Difference-in-means 
(weighted means): 4.71, 
p<0.001
Favorable
Note: All studies include adults aged ≥ 18 years with private insurance.
MH, mental health; pct pt, percentage point
Table D-2
Results of Studies Evaluating the Effect of Mental Health Parity on Guideline-Concordant 
Care
Author, year Need indicator Comparison Outcome Effect estimate Direction
























any MH/SA visit) 
first 2 months, ≥ 
2 per month
OR=1.09





any MH/SA visit) 
second 2 months, 
≥ 1 per month
OR=1.05
95% CI= 0.92, 
1.20; p>0.05
Null




Full parity Medicare plans 





















Adjusted for socio-demographic and health plan characteristics, clustering by plan, and repeated measurements of 
enrollees; both studies include adults aged ≥ 18 years.
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FEHB, Federal Employees Health Benefits Program; MH, mental health; SA, substance abuse
Table D-3
Results of Studies Evaluating the Effect of Mental Health Parity on Increasing Service 
Utilization Among Populations With an Identified Mental Health Need
Author, year Need Indicator Comparison Outcome Effect Estimate Direction
Harris, 200618 K6 Distress Scale 
>6
Parity states vs. 
weak/non-parity 
states
% any MH 
service use in 
past year
Absolute percentage point 
change=0.99
Favorable







Privately referred: DDD 
coeff=0.207, p<0.01
Total population: DDD 
coeff=0.128, p<0.05
Favorable





OLS coeff=0.827 p<0.01 Favorable

















All studies include adults ≥ 18 years of age with private or public insurance.
K6 Distress Scale: The Kessler 6 (K6) is a standardized and validated measure of nonspecific psychological distress.
Coeff, Coefficient; DDD, Difference-in-difference-in-difference; MH, mental health; MHI-5, Mental Health Inventory-5; 
OLS, ordinary least squares regression
Table D-4: Detailed Description
Subgroup analyses on strength and scope of legislation
Overall, six studies13–15,17,19,21 examined the impact of strength and scope of legislation on 
the outcomes of utilization, appropriate utilization, and suicide rates. The first group of 
studies had an indirect comparison of the effectiveness of comprehensive parity versus no/
weak parity to the effectiveness of all types of parity versus no/weak parity (these categories 
of parity are not mutually exclusive; Table D-4, top). Pacula and Sturm13 found differential 
effects for MH service visits among those identified with an MH need when analyzing 
comparisons of states with a strict parity mandate and states with all levels of parity 
(reference group: non-parity states). There were no such differences for the general 
population. Barry15 found no differential effects for more visits for MH specialty visits in 
full parity states comparisons than all levels of parity comparisons (reference group: no/
weak parity states). There were no differential effects for outcomes of proportion of mental 
health/substance abuse (MH/SA) users and specialty users. Klick and Markowitz21 found 
differential effects for greater reductions in adult suicide rates in states with full parity 
compared to states with more loosely defined parity mandates.
The second set of studies (Table D-4, bottom) had an indirect comparison of comprehensive 
parity to more limited forms of parity (i.e., weaker parity); these categories are mutually 
exclusive. Dave and Mukerjee19 reported a greater effect for broad parity legislation on 
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increasing SA treatment admissions, compared to limited parity legislation (reference group: 
weak/no parity states). Bao and Sturm14 reported a greater increase in the number of MH 
visits in states with strong parity mandates compared to states with medium parity mandates 
(reference group: weak/no parity). Trivedi and colleagues17 reported a larger improvement 
in follow-up (appropriate utilization) of previously hospitalized psychiatric patients, 
comparing those with a full parity Medicare plan to those with an intermediate parity 
Medicare plan.
Table D-4
Results of Studies Evaluating Strength and Scope of Parity Legislation
Comparative effectiveness of more comprehensive parity to all parity
Study (Years) Population Analysis: Outcome(s) Comparative effectivenessa,b Results Direction


































































Full Parity vs. No/weak parity A. Coefficient: −0.212
T-value: −0.27
Favorable
Parity vs. No/weak parity A. Coefficient: −0.0145
T-value: −0.17
Favorable
Comparative effectiveness of more comprehensive parity versus more limited parity
Study (Years) Population Analysis: Outcome(s) Comparative effectivenessa,b Results Direction






Broad vs. Non- parity A. Coefficient: 0.1278 (p<0.05)
SE=0.0512
Favorable
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Comparative effectiveness of more comprehensive parity to all parity









Limited vs. non-parity A. Coefficient: 0.0473 (p<0.1)
SE=0.0277
Favorable













Strong vs. No/weak parity A. 8.9
SE=4.9
Favorable
Medium vs. no/weak parity A. 5.3
SE=4.9
Favorable















Full vs. non- parity A. 10.5%
95% CI= 3.8, 17.1
B. 10.9%
95% CI= 4.6, 17.3
Favorable
Intermediate vs. non-parity A. 3.0 %
95% CI= −0.5, 6.5
B. 4.0 %
95% CI= 0.2, 7.8
Favorable
a
To assess effectiveness of more comprehensive legislation relative to more limited legislation, the results for the top box 
should be compared to those in the bottom box for the corresponding study.
b
Definition of terms used in this column:
Broad parity: coverage of a broad range of mental conditions
Full parity: insurers must provide mental health benefits at exactly the same terms applying to physical health 
benefits
Intermediate parity: mental health care greater than primary care cost sharing but less than or equal to specialist cost 
sharing
Limited parity: mental health benefits that apply to certain groups only e.g., those with severe biologically based 
mental illness, require parity for certain diagnoses (mandated offering), or require parity only if the plan already 
offers any type of mental health service (mandated if offered)
Medium parity: allow exemptions for small employers and employers that experience cost increase due to the law, 
may contain “if offered” provisions
No parity: no parity law or passed legislation matching the federal MHPA
Strict parity: laws that are more generous than the federal legislation
Strong parity: require equality in all cost-sharing and no exemptions
Weak parity: mandated offering
c
Uninsured not covered by parity legislation.
MH, mental health
Additional Evidence
Sixteen studies in 18 papers12,14,18–20,22–34 reported utilization of MH or SA services but 
did not provide sufficient information to meet the criteria for appropriate utilization. Results 
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were mixed, with eight studies14,18–20,24,27,33,35 indicating that implementation of MHBL 
was associated with increased utilization of any type of MH care, and three studies22,23,29 
reporting decreased utilization after implementation of either state mandates or FEHB 
(median 0.6 pct pts; IQI= −0.34, 1.83; 10 studies, 11 papers). Outpatient visits per 100 
members per year increased by a median of 5.4 following implementation of state parity 
mandates (IQI= −3.37, 34.77; 13 data points, 4 studies26,31,33,36); three additional 
studies18,25,34 that used different metrics for outpatient utilization had mixed results. 
Inpatient days per 1,000 members per year tended to decrease by a median of 13.47 
following implementation of state parity mandates (IQI= −74.05, −3.24; 9 data points, 4 
studies26,31,33,36); one additional study30 found a minimal decrease of 0.3 pct pts in MH/SA 
inpatient use.
Although not included in this review, there is also some evidence of favorable effects when 
employers voluntarily expanded MH/SA benefits to achieve parity. One study37 reported 
that a reduction in copayments resulted in increased utilization of substance use services. 
Two studies38,39 reported the combination of de-stigmatization and lower copayments was 
associated with a significant increase in the probability of initiating MH treatment by 1.2% 
and 0.74%, respectively (p<0.01 for each). And one study40 reported that benefit changes 
and de-stigmatization increased the likelihood of outpatient, pharmaceutical, or any MH 
treatment among intervention employers compared to control employers.
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Analytic framework: hypothesized ways in which mental health benefits legislation 
improves mental health.
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Flow chart showing number of studies identified, reviewed in full text, excluded, and total 
number included.
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Table 1
Results of Studies Evaluating Effect of Mental Health Parity Legislation on Utilization of Mental Health 
Specialists
Author, year Comparison Population Outcome Conclusion
McGuire, 198256 States with a mandate vs. states 
without a mandate
Adults with private 
insurance
Use of psychiatrists’ and 
psychologists’ services ▲
Pacula, 200035 Parity states vs. non-parity states Adults with private 
insurance
Number of specialty mental health 
visits ▲
Bao, 200439 Strong parity states vs. weak parity 
states
Adults with private 
insurance
Number of specialty mental health 
visits ▲
Barry, 200542 Parity states vs. non-parity states Adults with private 
insurance
Number of specialty mental health 
visits (weighted mean) ▲
▲ = favors parity; shape does not represent effect magnitude. All studies include adults aged ≥18 years with private insurance. See detailed data in 
Appendix Table D-1, available online.
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Table 2
Results of Studies Evaluating Effect of Mental Health Parity on Guideline-Concordant Care
Author, year Need indicator Population Outcome Conclusion
Busch, 200624
Diagnosis of major 
depressive disorder
Adults with private 
insurance
Receipt of any antidepressant and/or psychotherapy ▲
Duration of follow up (MH/SA visits and/or 
antidepressants) ≥4 months ▲
Intensity of follow-up (i.e. Any MH/SA visit) first 2 
months, ≥ 2 per month ○
Intensity of follow-up (i.e. Any MH/SA visit) second 
2 months, ≥1 per month ○
Trivedi, 200840
Previous hospitalization for 
psychiatric disorder
Adults with public 
insurance
7 day follow up for plans that continued full parity 
vs. plans that discontinued full parity (Adjusted* 
percentage point difference)
▲
30 day follow up for plans that continued full parity 




Adjusted for sociodemographic and health plan characteristics, clustering by plan, and repeated measurements of enrollees.
▲ = favors parity; ○ = null. Shapes do not represent effect magnitude. See detailed data in Appendix Table D-2, available online.
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Table 3
Effects of Mental Health Parity on Increasing Service Utilization Among Populations With an Identified 
Mental Health Need
Author, year Need Indicator Population Outcome Conclusion
Harris, 200612 K6 Distress Scale >6a Adults with employer-sponsored insurance % Past year any MH service 
use ▲
Dave, 200938 Privately referred Adults with public or private insurance or 
uninsured
Substance abuse treatment 
admissions (DDD) ▲
Pacula, 200035 MHI-5 <50b Adults with private insurance # MH specialty visits (OLS 
regression) ▲
Bao, 200439 MHI-5 <50b Adults with private insurance # MH specialty visits 
(standard error) ▲
Busch, 200846 MHI-5 <67b Adults, employer-sponsored insurance Any mental health service 
use (logistic regression) ▲
▲ = favors parity; Shapes do not represent effect magnitude.
a
K6 Distress Scale, The Kessler 6 (a standardized and validated measure of nonspecific psychological distress). (Cited from www.cdc.gov/
mentalhealth/data_stats/nspd.htm.)
b
MHI-5, Mental Health Inventory-5 (measures general psychological distress and well-being and used to assess mental health of consumers with a 
wide variety of conditions). (Cited from amhocn.org/static/files/assets/bae82f41/MHI_Manual.pdf.)
DDD, difference-in-difference-in-difference; MH, mental health; OLS, ordinary least squares See detailed data in Appendix Table D-3, available 
online.
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Table 4
Results of Studies Evaluating Strength and Scope of Parity Legislation
Comparative effectiveness of more comprehensive parity to all paritya
Author, year Population Comparative effectiveness Outcome Conclusion
Pacula, 200035 Adults with private insurance Strict parity to all parity
No. of MH visits for general population (no 
differences) ○
No. of MH visits among those with MH 
need (MHI-5<50) ▲
Barry, 200542 Adults with private insurance Full parity to all parity
Mean % of MH/SA users ○
Mean % of specialty MH users ○
Mean number of specialty visits ○
Klick, 200637
Adults with private or public 
insurance Full parity to all parity Adult suicide rate ▲
Comparative effectiveness of more comprehensive parity to more limited parityb
Author, year Population Comparative effectiveness Outcome Conclusion
Dave, 200938
Adults with public or private 
insurance, and adults without 
insurancec
Broad parity to limited parity Total SA treatment admissions ▲
Bao, 200439 Adults with private insurance
Strong parity to no/weak parity
Number of MH specialty visits ▲
Medium parity to no/weak parity
Trivedi, 200840 Adults with public insurance Full parity versus intermediate parity
% received follow-up in 7 days ▲
% received follow-up in 30 days ▲
▲ = differential effects favors comprehensive parity; ○ = no differential effects; shapes do not represent effect magnitude.
See detailed data in Appendix Table D-4, available online.
a
More comprehensive parity versus the reference group (no/weak parity) is indirectly compared to all parity vs. the reference group (weak/no 
parity). These groups are not mutually exclusive.
b
Mutually exclusive groups of more comprehensive parity are compared to more limited forms of parity (reference group in each comparison: no/
weak parity).
c
Uninsured population not covered by parity legislation.
MH, mental health; MHI-5, Mental Health Inventory-5; SA, substance abuse
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